|
Volume 10 Issue 3
|
|
Comment |
|
|
SELDI-TOF proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previously defined clusters from cDNA expression
Bashar A Zeidan, Paul A Townsend Breast Cancer Research 2008, 10:107 (30 June 2008)
Abstract | Full text | PDF | PubMed
|
|
Review |
|
|
Alternative splicing and the progesterone receptor in breast cancer
David MW Cork, Thomas WJ Lennard, Alison J Tyson-Capper Breast Cancer Research 2008, 10:207 (30 May 2008)
Abstract | Full text | PDF | PubMed
|
|
|
Are the so-called low penetrance breast cancer genes, ATM, BRIP1, PALB2 and CHEK2, high risk for women with strong family histories?
Graham B Byrnes, Melissa C Southey, John L Hopper Breast Cancer Research 2008, 10:208 (5 June 2008)
Abstract | Full text | PDF | PubMed
|
|
|
Mammographic density. Measurement of mammographic density
Martin J Yaffe Breast Cancer Research 2008, 10:209 (19 June 2008)
Abstract | Full text | PDF | PubMed
|
|
Research |
|
|
Antiproliferative and cytostatic effects of the natural product eupatorin on MDA-MB-468 human breast cancer cells due to CYP1-mediated metabolism
Vasilis Androutsopoulos, Randolph RJ Arroo, John F Hall, Somchaiya Surichan, Gerry A Potter Breast Cancer Research 2008, 10:R39 (2 May 2008)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
Editor’s summary
The flavone eupatorin, found in certain plants and used in folk medicine, selectively inhibits the growth of breast carcinoma cells through CYP1 family mediated metabolism, making it a potential chemopreventative candidate.
|
|
|
Autoantibodies as potential biomarkers for breast cancer
Li Zhong, Kun Ge, Jin-chi Zu, Long-hua Zhao, Wei-ke Shen, Jian-fei Wang, Xiao-gang Zhang, Xu Gao, Wanping Hu, Yun Yen, Kemp H Kernstine Breast Cancer Research 2008, 10:R40 (7 May 2008)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
Editor’s summary
Serum autoantibody profiling is a promising approach for early detection and diagnosis of breast cancer, and a panel of autoantibodies appears preferable to achieve superior accuracy.
|
|
|
Breast cancer tumor growth estimated through mammography screening data
Harald Weedon-Fekjær, Bo H Lindqvist, Lars J Vatten, Odd O Aalen, Steinar Tretli Breast Cancer Research 2008, 10:R41 (8 May 2008)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
Editor’s summary
A new model which can estimate the growth rate of breast cancer, as well as the proportion of tumors detected at screening, shows slower growth rates with increasing age.
|
|
|
Intact and total insulin-like growth factor-binding protein-3 (IGFBP-3) levels in relation to breast cancer risk factors: a cross-sectional study
Caroline Diorio, Jacques Brisson, Sylvie Bérubé, Michael Pollak Breast Cancer Research 2008, 10:R42 (9 May 2008)
Abstract | Full text | PDF | PubMed
|
|
|
Estrogen and progesterone induce persistent increases in p53-dependent apoptosis and suppress mammary tumors in BALB/c-Trp53+/- mice
Karen A Dunphy, Anneke C Blackburn, Haoheng Yan, Lauren R O'Connell, D Joseph Jerry Breast Cancer Research 2008, 10:R43 (12 May 2008)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
TIMP-2 mediates the anti-invasive effects of the nitric oxide-releasing prodrug JS-K in breast cancer cells
Ann-Marie Simeone, Vanity McMurtry, René Nieves-Alicea, Joseph E Saavedra, Larry K Keefer, Marcella M Johnson, Ana M Tari Breast Cancer Research 2008, 10:R44 (12 May 2008)
Abstract | Full text | PDF | PubMed
|
|
|
Serum biomarker profiles and response to neoadjuvant chemotherapy for locally advanced breast cancer
Brian M Nolen, Jeffrey R Marks, Shlomo Ta'san, Alex Rand, The Luong, Yun Wang, Kimberly Blackwell, Anna E Lokshin Breast Cancer Research 2008, 10:R45 (12 May 2008)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors
Eiji Sunami, Masaru Shinozaki, Myung-Shin Sim, Sandy L Nguyen, Anh-Thu Vu, Armando E Giuliano, Dave SB Hoon Breast Cancer Research 2008, 10:R46 (16 May 2008)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
Effects of common germline genetic variation in cell cycle control genes on breast cancer survival: results from a population-based cohort
Elizabeth M Azzato, Kristy E Driver, Fabienne Lesueur, Mitul Shah, David Greenberg, Douglas F Easton, Andrew E Teschendorff, Carlos Caldas, Neil E Caporaso, Paul DP Pharoah Breast Cancer Research 2008, 10:R47 (28 May 2008)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
Surface-enhanced laser desorption/ionization time-of-flight proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previously defined clusters from cDNA expression
Kristyna Brozkova, Eva Budinska, Pavel Bouchal, Lenka Hernychova, Dana Knoflickova, Dalibor Valik, Rostislav Vyzula, Borivoj Vojtesek, Rudolf Nenutil Breast Cancer Research 2008, 10:R48 (29 May 2008)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
Editor’s summary
SELDI-TOF mass spectometry profiling produces similar clustering of tumours to microarray-based gene expression profiling, and has the potential to identify novel biomarkers and produce clinically useful classifications of breast carcinomas.
|
|
|
Expression of the epidermal growth factor receptor (EGFR) and the phosphorylated EGFR in invasive breast carcinomas
Christina Magkou, Lydia Nakopoulou, Christina Zoubouli, Kanelina Karali, Irene Theohari, Panagiotis Bakarakos, Ioanna Giannopoulou Breast Cancer Research 2008, 10:R49 (3 June 2008)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
Mammary carcinoma behavior is programmed in the precancer stem cell
Patrizia Damonte, J Graeme Hodgson, Jane Chen, Lawrence JT Young, Robert D Cardiff, Alexander D Borowsky Breast Cancer Research 2008, 10:R50 (3 June 2008)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
Editor’s summary
Studies in a mouse model establish a "pre-cancer" stem cell as the origin of invasive cancer, suggesting the risk of advancing to invasive breast cancer may be predictable at the precancer stage.
|
|
|
Jab1 is a target of EGFR signaling in ERα-negative breast cancer
Jiaxu Wang, Rebecca O Barnes, Nathan R West, Melanie Olson, Jenny E Chu, Peter H Watson Breast Cancer Research 2008, 10:R51 (6 June 2008)
Abstract | Full text | PDF | PubMed
|
|
|
Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells
Matthew J Grimshaw, Lucienne Cooper, Konstantinos Papazisis, Julia A Coleman, Hermann R Bohnenkamp, Laura Chiapero-Stanke, Joyce Taylor-Papadimitriou, Joy M Burchell Breast Cancer Research 2008, 10:R52 (9 June 2008)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
Editor’s summary
Mammosphere culture of metastatic cells from pleural effusions enriches for tumour-inducing cells, and could represent a novel model for studying tumorigenic 'stem' cell sensitivity to therapeutic agents.
|
|
|
The CD44+/CD24- phenotype is enriched in basal-like breast tumors
Gabriella Honeth, Pär-Ola Bendahl, Markus Ringnér, Lao H Saal, Sofia K Gruvberger-Saal, Kristina Lövgren, Dorthe Grabau, Mårten Fernö, Åke Borg, Cecilia Hegardt Breast Cancer Research 2008, 10:R53 (17 June 2008)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
Editor’s summary
Basal-like and particularly BRCA1 hereditary breast cancer are associated with CD44+/CD24- cells, however tumorigenicity may not be confined to cells of this phenotype as they are found in very few HER2+ tumours.
|
|
|
PMC42, a breast progenitor cancer cell line, has normal-like mRNA and microRNA transcriptomes
Anna Git, Inmaculada Spiteri, Cherie Blenkiron, Mark J Dunning, Jessica CM Pole, Suet-Feung Chin, Yanzhong Wang, James Smith, Frederick J Livesey, Carlos Caldas Breast Cancer Research 2008, 10:R54 (27 June 2008)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
Editor’s summary
Breast cancer cell line PMC42 is a good model for normal breast epithelium, providing a unique biological tool to study breast differentiation and the function of key miRNAs typically lost in cancer.
|
|
Correspondence |
|
|
The future of mammary stem cell biology: the power of in vivo transplants
Geoffrey J Lindeman, Jane E Visvader, Matthew J Smalley, Connie J Eaves Breast Cancer Research 2008, 10:402 (29 May 2008)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
The future of mammary stem cell biology: the power of in vivo transplants – authors' response
Gilbert H Smith, Daniel Medina Breast Cancer Research 2008, 10:403 (29 May 2008)
Abstract | Full text | PDF
|